With the website https://www.biotech-investments.com and the Biotech Investments MAGAZINE we provide private investors with access to high-quality information on biotech companies with exceptional growth potential. Our team consists of specialists holding a PhD degree in molecular biology with many years of professional experience in the biotech and pharmaceutical industries.
The Biotech Investments Model Portfolio offers a transparent opportunity to track and replicate our investment strategy. The so-called Evidence-based Investment Strategy was developed by Biotech Investments and builds on a medical-scientific analysis of the companies’ research and development pipelines. We exclusively focus on companies with drug candidates that already demonstrated groundbreaking results in phase 2 clinical trials. This significantly increases the likelihood of positive outcomes of the subsequent phase 3 trials and regulatory approval.
The task of Biotech Investments lies solely in providing high-quality information, we are not an investment company.